Formation of cardiogenic pulmonary edema in acute left heart failure is traditionally attributed to increased fluid filtration from pulmonary capillaries and subsequent alveolar flooding. Here, we demonstrate that hydrostatic edema formation at moderately elevated vascular pressures is predominantly caused by an inhibition of alveolar fluid reabsorption which is mediated by endothelial-derived nitric oxide (NO). In isolated rat lungs, we quantified fluid fluxes into and out of the alveolar space and endothelial NO production by a two-compartmental double-indicator dilution technique and in situ fluorescence imaging, respectively. Elevation of hydrostatic pressure induced Ca 2+ -dependent endothelial NO production and caused a net fluid shift into the alveolar space which was predominantly attributable to impaired fluid reabsorption.
INTRODUCTION
Hydrostatic lung edema results from increased fluid filtration across the lung microvascular barrier due to elevated hydrostatic or reduced oncotic pressures in lung microvessels (18). Initially, the edema is confined to the interstitial space and limited by the powerful lymphatic drainage (39), a low interstitial compliance (38, 39), and the tight alveolar membrane (50). When these protective mechanisms are finally exceeded, fluid enters the airspace resulting in alveolar flooding and impaired gas exchange (5) .
Alveolar fluid influx is counteracted by alveolar fluid clearance, an active reabsorption process in the alveolar space and the distal airways by which epithelial cells remove fluid back into the pulmonary interstitium and vasculature. Epithelial reabsorption of alveolar fluid is chiefly attributable to active Na + -transport via Na + transporters in the apical plasma membrane and the basolaterally located Na + /K + -ATPase (24, 34). In patients with severe hydrostatic lung edema, alveolar fluid reabsorption was found to be impaired or submaximal in 62% of cases, type II epithelial cells, but both stimulation and inhibition of transport characteristics have been reported depending on the amount of NO and the period of exposure. On the one hand, exogenous NO donors or cyclic GMP (cGMP) analogs reduce the opening probability of the apical Na + -permeant cation channel in isolated type II pneumocytes (27), decrease Na + transport across confluent type II monolayers (17) and reduce amiloride-sensitive fluid clearance in vivo (41). Transgenic lack or inhibition of the inducible NO synthase (iNOS), on the other hand, also reduces amiloride-sensitive Na + transport and fluid clearance (19, 20) , presumably via a posttranscriptional downregulation of the and subunits of the epithelial Na + channel (ENaC) (20).
Chronic congestive heart failure (CHF) induces lung endothelial dysfunction (40) and thus, reduces NO bioavailability in the aispaces (1, 49) . Notably, CHF patients are also protected from hydrostatic lung edema (11, 12), and regulation of fluid reabsorption by NO may establish a causative link between both findings.
Here, we investigated the effect of hydrostatic stress in lung capillaries on alveolar fluid reabsorption and its mediation by NO in isolated mouse and rat lungs and in lungs from rats with CHF. Our findings identify a novel crosstalk between the capillary and the alveolar compartment that may constitute an important mechanism in the pathogenesis of hydrostatic lung edema. capillaries were viewed at a focal plane corresponding to maximum diameter (14-30 µm).
Exposure time for each single image was limited to 5 milliseconds. Fluorescence images obtained in 10 s intervals were background-corrected and fluorescence intensity (F) was expressed relative to its individual baseline (F 0 ). Since the conversion of DAF-FM to the benzotriazole derivative is irreversible, the ratio F/F 0 reflects NO production integrated over time.
Two-compartmental double indicator dilution technique
Fluid fluxes into and out of the alveolar space were quantified by a double indicator dilution technique. A high molecular weight fluorescence tracer, texas red dextran (TRD), was instilled into the alveolar space for determination of alveolar net fluid shift while a low molecular weight tracer, Na + fluorescein (NaF), was added to the perfusate to allow for differentiation between alveolar fluid influx and alveolar fluid reabsorption. At time -10, 0 and 60 min samples were drawn from both compartments and alveolar fluid reabsorption, alveolar fluid influx and net fluid shift were calculated assuming a two-compartmental model. Physiological assumptios and mathematical algorithms underlying this model are presented and discussed in an online supplement to this manuscript. respectively. 5.) Pharmacological interventions: The NO synthase inhibitor N -nitro-L-arginine methyl ester (L-NAME; 250 µMol/L), the phosphatidylinositol-3-OH kinase (PI3K) inhibitor Ly294002 (10 µMol/L) and the exogenous NO donors S-nitroso glutathione (GSNO; 100 µMol/L) and
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NONOate; 100µMol/L), respectively, were added to the perfusate. The soluble guanlyate cyclase inhibitor 1H-[1,2,4]oxadiazoloquinoxalin-1-one (ODQ; 100 µMol/L), the cGMP analog 8Br-cGMP (1 mMol/L), L-NAME (250 µMol/L), the sodium channel inhibitor amiloride (10 µMol/L), the Na + ,K + -ATPase inhibitor Ouabain (100µMol/L) and dopamine (100 µMol/L) were administered with the alveolar tracer solution into the airspace.
Statistical analysis
All data are given as mean ± SEM. Different groups were compared by Mann-Whithney U-test by using SigmaStat software (SigmaStat 3.10; Systat Software GmbH, Erkrath, Germany).
Linear and non-linear regression analyses were performed by using GraphPad Prism software (Version 4.0, GraphPad Software Inc., San Diego, CA). Statistical significance was assumed at p < 0.05.
RESULTS

Two-compartmental double indicator dilution technique
A double indicator dilution technique was used to differentiate between alveolar fluid influx and reabsorption kinetics in the isolated perfused rat lung. The model is based on the assumption that the distribution of the high molecular weight tracer TRD is confined to the alveolar compartment, whereas the low molecular weight tracer NaF reflects fluid fluxes into and out of the alveolar space due to its rapid convective transport. Within the investigated hydrostatic pressure range of 5 to 15 cmH 2 O, TRD was strictly confined to the alveolar compartment as demonstrated by its absence in the perfusate (Fig. 1A) . In contrast, decompartmentalization at the alveolo-capillary barrier resulted in a marked translocation of the dye into the vascular space independent of the applied vascular pressure (Fig. 1A) .
Pressure-dependent fluid shifts across the alveolo-capillary barrier
In isolated perfused rat lungs, the net fluid shift into the alveolar space was determined from the kinetics of the alveolar TRD concentration. At P LA of 5 cmH 2 O, net fluid shift was close to 0 ml/h (Fig. 1B) since fluid influx into and fluid reabsorption out of the alveolar space were in balance (Fig. 1C ). With higher P LA , net fluid shift increased exponentially indicating progressive alveolar flooding (Fig. 1C ). This effect was not only attributable to increased fluid filtration, but also to a marked reduction in alveolar fluid reabsorption. Although alveolar fluid influx increased with higher P LA , yet without reaching significance (p<0.09), this effect contributed only ~30 % to the total increase in net fluid shift. The predominant cause of the net fluid shift was an exponential decrease of alveolar fluid reabsorption which even became negative at P LA of 15
Endothelial-derived NO regulates alveolar fluid reabsorption
To investigate the role of NO in hydrostatic edema formation, we determined wet/dry weight ratios in isolated mouse lungs following 25 min of perfusion at control P LA of 2 cmH 2 O or at elevated P LA of 6 cmH 2 O. Whereas P LA elevation resulted in massive edema formation in control lungs as indicated by a 2.5fold increase in wet/dry weight ratios, this effect was markedly attenuated in the presence of the NO synthase inhibitor L-NAME (Fig. 2) . A similar reduction in wet/dry weight ratios was detected in mice deficient of endothelial NO synthase. Capillary pressures increased identically in control and treatment groups (Fig 2B) , suggesting that differences in hydrostatic edema formation were attributable to NO production by eNOS. Neither L-NAME nor eNOS deficiency had an effect on lung wet/dry weight ratio at physiological P LA of 2 cmH 2 O.
The finding that eNOS-derived NO causes lung edema at increased hydrostatic pressure, but not at baseline P LA , suggests that eNOS activity may be pressure-regulated. As demonstrated by stable DAF-FM fluorescence in isolated perfused rat lungs (Figs. 3A,B) , endothelial NO production was below the detection limit at baseline P LA . Elevation of P LA increased DAF-FM fluorescence in the capillary wall which was blocked by L-NAME (Figs. 3A,B) . As we discuss later, this finding indicates pressure-induced endothelial NO formation which coincided with impaired alveolar fluid reabsorption.
Next, we studied the effects of NO on alveolar fluid reabsorption in the isolated perfused rat lung. At baseline P LA , lung perfusion with the exogenous NO donors GSNO or papaNONOate, respectively, completely blocked alveolar fluid reabsorption, but had no significant effect on alveolar fluid influx ( Fig. 3C ). At P LA of 15 cmH 2 O, lung perfusion with L-NAME fully reconstituted alveolar fluid reabsorption to baseline values (Fig. 3D ). The recovery with either Ca 2+ -free solution or the PI3K inhibitor Ly294002, intact alveolar fluid reabsorption was preserved at elevated P LA of 15 cmH 2 O whereas no significant effect on alveolar fluid influx was detectable (Fig. 4C ). These findings support the notion that pressure-induced Ca 2+ -and PI3K-dependent endothelial NO production promotes hydrostatic edema formation by impairing alveolar fluid reabsorption.
Since oxyhemoglobin within red blood cells is a potent endogenous scavenger of NO and may thus limit or even neutralize the effects of endothelial-derived NO in vivo, we determined the effects of hydrostatic stress on alveolar fluid reabsorption in lungs perfused with autologous blood. In the presence of red blood cells, P LA elevation again reduced alveolar fluid reabsorption, yet to a lesser extent as compared to buffer-perfused rat lungs (Fig. 4D ). These data are in line with the finding that inhibition of alveolar fluid reabsorption was NO-dependent and extend the relevance of this mechanism to the blood-perfused lung.
To mimic downstream signaling effects of endothelial-derived NO in intact alveolar epithelium, we instilled lungs with the cell-permeable cGMP-analog 8Br-cGMP. At baseline P LA of 5 cmH 2 O, 8Br-cGMP reduced alveolar fluid clearance, thus evoking a similar response as P LA elevation ( Fig. 5A ). In contrast, inhibition of cGMP formation by the soluble guanylate-cyclase inhibitor ODQ rescued intact alveolar fluid clearance at elevated P LA (Fig. 5B) . A similar preservation of fluid clearance was achieved by alveolar instillation of dopamine ( Fig. 5C ) which increases epithelial Na + transport, presumably by increasing basolateral surface expression of
To further analyze the mechanisms by which NO may impair alveolar fluid reabsorption
we assessed (i) whether inhibitors of the apical Na + channel or the basolateral Na + ,K + -ATPase may mimic the effects of hydrostatic stress, and (ii) whether these blockers may evoke an additive inhibitory effect on alveolar fluid reabsorption at elevated P LA . At baseline P LA of 5 cmH 2 O, both the Na + ,K + -ATPase inhibitor ouabain and the Na + channel blocker amiloride reduced alveolar fluid reabsorption to or even below ~0 ml/h, respectively (Fig. 6A ). At elevated P LA of 15 cmH 2 O, amiloride did not further reduce alveolar fluid reabsorption, whereas ouabain reset fluid clearance to ~0 ml/h, thus effectively increasing it as compared to control values (Fig.   6B ). As we discuss later, this finding indicates that hydrostatic stress impairs fluid reabsorption by inhibition of apical Na + channels, whereas the Na + ,K + -ATPase contributes to active alveolar fluid secretion during hydrostatic stress.
Alveolar fluid reabsorption in congestive heart failure
To elucidate mechanisms contributing to the partial protection of CHF patients against hydrostatic lung edema, we studied alveolar fluid reabsorption in a supracoronary aortic banding model of CHF in rats. Functional fluorescence imaging of DAF-FM loaded endothelial cells revealed that the fluorescence response to P LA elevation is abrogated in lungs of CHF rats ( In rats with congestive heart failure, lack of endothelial NO production contributes to intact alveolar fluid reabsorption, thus protecting the lungs from alveolar flooding. These findings present a novel mechanism in the pathogenesis of hydrostatic lung edema with potential therapeutic implications and characterize a new signaling pathway between the capillary and the alveolar compartments of the lung.
Hydrostatic edema and impaired alveolar fluid reabsorption
Hydrostatic lung edema was evident in isolated perfused rat lungs at P LA of 15 cmH 2 O as net fluid shift into the alveolar space. This finding is in accordance with previous data demonstrating alveolar flooding and increased solute flux into the alveolar space of rats at P LA of 15-20 cmH 2 O (23, 46). In larger mammels, alveolar edema only occurs when P LA exceeds 30 cmH 2 O (16, 18), suggesting that comparable fluid shifts will require considerably higher levels of hydrostatic stress in humans. Conversely, lower vascular pressures had to be applied in isolated perfused mouse lung experiments in this study to avoid rapid microvascular stress failure and excessive edema formation. The relative pressure increase as compared to experiments in isolated rat lungs was conserved by tripling of the respective baseline P LA . P LA elevation from 2 to 6 cmH 2 O was sufficient to cause a 2.5-fold increase in wet/dry weight ratio in mice. This pressure increase will also change zonal perfusion in the lung which may contribute to edema formation by recruitment of previously unperfused capillaries (53). The same mechanism may also add to pressure-induced net fluid shifts in the isolated rat lung. Importantly, the potential impact of capillary recruitment does not compromise our findings on the role of endothelial-derived NO in the regulation of alveolar fluid reabsorption, since all pharmacological interventions or transgenic models were compared to respective controls at similar vascular pressures. Pulmonary edema in these models was furthermore not attributable to lung injury as indicated by lack of edema at baseline pressure and absence of TRD tracer translocation into the perfusate. Of note, hydrostatic lung edema can be expected to be less pronounced in vivo when lymphatic pulmonary drainage is intact.
The alveolar epithelium rather than the endothelial layer constitutes the critical membrane . These data clearly identify the endothelium as the predominant source of NO in acute hydrostatic stress. This finding is further supported by data from the present study demonstrating that hydrostatic edema is signficantly attenuated in eNOS -/-mice and that blocking of all NOS isoforms by L-NAME does not further reduce lung wet/dry weight ratio.
Inhibition of the endothelial NO response by L-NAME, Ca 2+ free perfusion (28) or PI3K inhibition (29) reconstituted alveolar fluid reabsorption in rat lungs, confirming the hypothesis that fluid reabsorption at elevated P LA was impaired by endothelial NO production. This notion is further supported by the finding that reconstitution of fluid reabsorption was less pronounced when L-NAME was administered via the alveolar rather than the capillary route. In contrast, 
Regulation of epithelial Na + transport
Alveolar fluid reabsorption is primarily driven by active transport of ions, in particular Na + , across the alveolar epithelium (36, 37). Alveolar transepithelial Na + transport occurs predominantly via sodium uptake by amiloride-sensitive Na + channels at the apical membrane to the inhibitory effect of NO on amiloride-sensitive Na + channels (45). Yet, since inhibitors of Snitrosylation such as N-ethylmalmeimide also decrease basal Na + currents in alveolar epithelial cells and accordingly, result in rapid edema formation (data not shown), the evaluation of these mechanisms remains subject to future studies.
Alveolar fluid reabsorption in congestive heart failure
Both clinical and experimental studies demonstrate that hydrostatic edema formation is attenuated in lungs exposed to chronic hydrostatic stress (11, 51). Recently, considerable research has focussed on structural and functional adaptations that may limit alveolar fluid influx from lung microvessels in congestive heart failure (2, 25) . Here, we propose preservation of intact alveolar fluid reabsorption as additional protective mechanism. Whereas elevation of P LA to 15 
Clinical significance
The present study was conducted in isolated perfused lungs from small rodents which are more sensitive to hydrostatic stress than larger mammals and lack physiological protection mechanisms such as lymphatic draninage. Yet, clinical data support the potential relevance of this novel pathomechanism in humans. In a previous study of 65 patients diagnosed with severe hydrostatic lung edema, alveolar fluid clearance was severely impaired in 25% and submaximal in 37%, thus constituting a potentially relevant pathogenetic factor in almost 2/3 of patients (52).
In agreement with a central role for NO in this process, submaximal or impaired alveolar fluid clearance was associated with signficantly higher concentrations of nitrate and nitrite in edema fluid from patients with either hydrostatic lung edema or acute lung injury (54). While the potential relevance of impaired fluid clearance due to therapeutic delivery of exogenous NO donors or inhaled NO may frequently be obscured by hemodynamic effects which promote the resolution of lung edema (10, 47), inhaled NO has been shown to cause pulmonary edema in patients with NYHA III congestive heart failure (6). Hence, inhibition of alveolar fluid reabsorption by endothelial-derived NO may constitute a relevant and so far unrecognized mechanism in the pathogenesis of hydrostatic lung edema. 
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